Trial to Evaluate the Efficacy of GSK Biologicals' Influenza Vaccine GSK2186877A in Adults 65 Year of Age and Older
NCT00753272
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
43695
Enrollment
INDUSTRY
Sponsor class
Conditions
Influenza
Interventions
BIOLOGICAL:
GSK Bio's influenza vaccine GSK2186877A
BIOLOGICAL:
Fluarix TM
Sponsor
GlaxoSmithKline